Evaluation of Hemodynamic Effects of Cascade Hemofiltration in Septic Shock (Cascade)
Sponsor: Baxter Healthcare Corporation
A NA clinical study on Sepsis, this trial is completed. The trial is conducted by Baxter Healthcare Corporation and has accumulated 8 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Apr 2025 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — Apr 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
May 2017 — Jun 2018 [monthly]
Completed NA
Phase: PHASE3 → NA
-
Jan 2017 — May 2017 [monthly]
Completed PHASE3
First recorded
Apr 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baxter Healthcare Corporation
- Gambro Lundia AB
- Vantive Health LLC
For direct contact, visit the study record on ClinicalTrials.gov .